Content about Fabry disease

May 3, 2012

Orphan drugs to see growth through 2018, report finds

Drug makers could strike big with new treatments for rare diseases, according to a new report by a market research firm.

November 23, 2011

Shire seeks approval to make Gaucher disease drug at new plant

British drug maker Shire is looking to make a biotech drug for a rare genetic disorder at a new manufacturing plant in Massachusetts.

September 15, 2011

GSK, Amicus start phase-3 trial of Fabry disease drug

GlaxoSmithKline and Amicus Therapeutics have started a late-stage clinical trial for a drug to treat a rare genetic disorder, the companies said.

April 7, 2011

Pfizer, Zacharon enter collaboration

Pfizer is partnering with San Diego biotech company Zacharon Pharmaceuticals to develop treatments for rare genetic disorders Zacharon said Thursday.

March 7, 2011

Genzyme's board recommends shareholders OK Sanofi offer

The board of directors of Genzyme unanimously recommended that shareholders accept French drug maker Sanofi-Aventis’ $74-per-share buyout offer, Genzyme said Monday.

February 16, 2011

Amicus' Amigal improves symptoms among Fabry disease patients in trial

Amicus Therapeutics received good results from its mid-stage trial of a drug for a rare, genetic disorder, the drug maker said Wednesday.

December 13, 2010

Genzyme (again) turns down Sanofi-Aventis

Biotech company Genzyme still is saying “no thanks” to French drug maker Sanofi-Aventis’ tender offer of $18.5 billion, or $69 per share, to acquire it, saying the offer “substantially undervalues” the company.

October 28, 2010

GSK, Amicus to develop, commercialize Amigal

British drug maker GlaxoSmithKline will work with U.S.-based Amicus Therapeutics to develop a drug for...

October 7, 2010

Genzyme again rejects Sanofi buyout offer

The board of directors of Genzyme again has rejected a buyout offer by French drug...

August 25, 2010

Sanofi unwilling to increase bid with Genzyme

Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble,...

July 7, 2010

Genzyme, Hospira reportedly ink packaging deal

Generic drug maker Hospira will fill and package several drugs for Genzyme, according to published...